Endo sues Impax over oxymorphone HCl
The Philadelphia Business Journal reports:
Hayward, Calif.-based Impax has applied to make a generic form of the pain drug known as Opana ER. Endo (NASDAQ:ENDP) and Penwest Pharmaceuticals Co., which make and sell Opana ER, sued Impax based on an amendment to that application. The amendment added new dosages of the drug — 7.5 mg, 15 mg and 30 mg.
The St. Louis Business Journal reports:
Energizer Holdings Inc. said Monday [July 28] it filed a lawsuit against Spectrum Brands, alleging the company's lithium batteries infringe on two of its patents.
Hayward, Calif.-based Impax has applied to make a generic form of the pain drug known as Opana ER. Endo (NASDAQ:ENDP) and Penwest Pharmaceuticals Co., which make and sell Opana ER, sued Impax based on an amendment to that application. The amendment added new dosages of the drug — 7.5 mg, 15 mg and 30 mg.
The St. Louis Business Journal reports:
Energizer Holdings Inc. said Monday [July 28] it filed a lawsuit against Spectrum Brands, alleging the company's lithium batteries infringe on two of its patents.
posted by Lawrence B. Ebert at 4:29 PM
0 Comments:
Post a Comment
<< Home